Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors. [PDF]
Stromatt JC +6 more
europepmc +1 more source
Drug Interaction PBPK Modeling: Review of the Literature Exposes the Need for Increased Verification of Model Inputs and Outputs as Part of Credibility Assessment. [PDF]
Rodrigues D, Gibson CR, Isoherranen N.
europepmc +1 more source
Substrate Specificity of the Organic Cation Transporters MATE1 and MATE2K and Functional Overlap with OCT1 and OCT2. [PDF]
Redeker KM +4 more
europepmc +1 more source
Coupled Heterogeneity to Dimeric Site-Specific Binding by the POU-Family Transcription Factor OCT2. [PDF]
Terrell JR, Poon GMK.
europepmc +1 more source
Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine-Metformin Interaction. [PDF]
Ailabouni AS +6 more
europepmc +1 more source
Modulatory effect of metformin and its transporters on immune infiltration in tumor microenvironment: a bioinformatic study with experimental validation. [PDF]
Rashad AA +3 more
europepmc +1 more source
Molecular pharmacokinetic mechanism of quercetin-encapsulated polymeric micelles in alleviating cisplatin-induced nephrotoxicity and enhancing antineoplastic effects. [PDF]
Hao T +7 more
europepmc +1 more source
Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications. [PDF]
Koo N +4 more
europepmc +1 more source
PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Gąsowska-Bodnar A +4 more
europepmc +1 more source
From Polymers to Rings and Back Again: Chemical Recycling of Polyesters to Macrolactones. [PDF]
Smith ML +3 more
europepmc +1 more source

